Chinese venture capital (VC) firm Alwin Capital has secured the final close of a dual-currency fund at $300 million to invest in life and interdisciplinary sciences, according to a company announcement.
The RMB investors of the dual-currency fund include large fund of funds (FoFs), Chinese government guidance funds, medical industry and insurance companies, banks, and other financial institutions in China, the company said without divulging names.
